- Home
- SPXX vs OSUR Comparison
SPXX vs OSUR Comparison
Compare SPXX & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPXX
- OSUR
- Stock Information
- Founded
- SPXX 2004
- OSUR 2000
- Country
- SPXX United States
- OSUR United States
- Employees
- SPXX N/A
- OSUR N/A
- Industry
- SPXX Trusts Except Educational Religious and Charitable
- OSUR Medical/Dental Instruments
- Sector
- SPXX Finance
- OSUR Health Care
- Exchange
- SPXX Nasdaq
- OSUR Nasdaq
- Market Cap
- SPXX 294.7M
- OSUR 334.1M
- IPO Year
- SPXX N/A
- OSUR 1986
- Fundamental
- Price
- SPXX $16.89
- OSUR $4.13
- Analyst Decision
- SPXX
- OSUR Buy
- Analyst Count
- SPXX 0
- OSUR 3
- Target Price
- SPXX N/A
- OSUR $6.67
- AVG Volume (30 Days)
- SPXX 51.3K
- OSUR 459.6K
- Earning Date
- SPXX 01-01-0001
- OSUR 11-05-2024
- Dividend Yield
- SPXX 7.55%
- OSUR N/A
- EPS Growth
- SPXX N/A
- OSUR N/A
- EPS
- SPXX N/A
- OSUR 0.36
- Revenue
- SPXX N/A
- OSUR $273,535,000.00
- Revenue This Year
- SPXX N/A
- OSUR N/A
- Revenue Next Year
- SPXX N/A
- OSUR N/A
- P/E Ratio
- SPXX N/A
- OSUR $11.35
- Revenue Growth
- SPXX N/A
- OSUR N/A
- 52 Week Low
- SPXX $13.57
- OSUR $3.92
- 52 Week High
- SPXX $16.05
- OSUR $8.45
- Technical
- Relative Strength Index (RSI)
- SPXX 61.69
- OSUR 45.49
- Support Level
- SPXX $16.77
- OSUR $4.00
- Resistance Level
- SPXX $16.87
- OSUR $4.16
- Average True Range (ATR)
- SPXX 0.11
- OSUR 0.08
- MACD
- SPXX 0.01
- OSUR 0.01
- Stochastic Oscillator
- SPXX 93.73
- OSUR 57.89
About SPXX Nuveen S&P 500 Dynamic Overwrite Fund
Nuveen S&P 500 Dynamic Overwrite Fund is a diversified closed-end management investment company. Its investment objective is to seek attractive total returns with less volatility than the S&P 500 Index by investing in a U.S. equity portfolio that seeks to substantially replicate the price movements of the S&P 500 Index, as well as selling call options on 35%-75% of the notional value of the Fund's equity portfolio (with a 55% long-term target) in an effort to enhance the Fund's risk-adjusted returns.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.